equol has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, S; Kim, JH; Lim, C | 1 |
| Deng, XL; Li, GR; Wang, Y; Yu, W; Zhao, LM; Zhou, DX | 1 |
2 other study(ies) available for equol and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Ischemic-time associated reductions in equol monosulfate plasma levels in a mouse model of ischemic stroke: support the existence of a 'brain-gut axis'.
Topics: Animals; Brain Edema; Brain-Gut Axis; CA1 Region, Hippocampal; Cerebral Cortex; Disease Models, Animal; Equol; Gastrointestinal Microbiome; Hippocampus; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; Mice, Inbred C57BL; Neurons; Sulfates; Time Factors | 2021 |
Equol is neuroprotective during focal cerebral ischemia and reperfusion that involves p-Src and gp91(phox).
Topics: Animals; Brain Infarction; Disease Models, Animal; Equol; Gene Expression Regulation; Glucose; Hypoxia; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Male; Malondialdehyde; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Nervous System Diseases; Neuroprotective Agents; PC12 Cells; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); Rats; Rats, Sprague-Dawley; Reperfusion | 2014 |